"non small cell lung cancer" trang 15 - tải miễn phí từ tailieunhanh
Cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non–small cell lung cancer: A modelling approach

Cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non–small cell lung cancer: A modelling approach
10    7    1
Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements

Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements
12    6    1
Clinical benefit of pembrolizumab in treatment of first line non-small cell lung cancer: A systematic review and meta-analysis of clinical characteristics

Clinical benefit of pembrolizumab in treatment of first line non-small cell lung cancer: A systematic review and meta-analysis of clinical characteristics
17    7    1
The timing of durvalumab administration affects the risk of pneumonitis in patients with locally advanced non-small cell lung cancer: A systematic review and meta-analysis

The timing of durvalumab administration affects the risk of pneumonitis in patients with locally advanced non-small cell lung cancer: A systematic review and meta-analysis
12    7    1
Genome-wide DNA methylation signature predict clinical benefit of bevacizumab in non-small cell lung cancer

Genome-wide DNA methylation signature predict clinical benefit of bevacizumab in non-small cell lung cancer
10    1    1
Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling

Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling
10    1    1
Effect of EGFR amplification on the prognosis of EGFR-mutated advanced non–small-cell lung cancer patients: A prospective observational study

Effect of EGFR amplification on the prognosis of EGFR-mutated advanced non–small-cell lung cancer patients: A prospective observational study
10    5    1
Efficacy and safety analyses of epidermal growth factor receptor tyrosine kinase inhibitors combined with chemotherapy in the treatment of advanced non–small-cell lung cancer with an EGFR/TP53 co-mutation

Efficacy and safety analyses of epidermal growth factor receptor tyrosine kinase inhibitors combined with chemotherapy in the treatment of advanced non–small-cell lung cancer with an EGFR/TP53 co-mutation
12    5    1
Rationale and protocol design of a phase II study of first-line osimertinib treatment for patients with poor performance status and EGFR mutation-positive non-small cell lung cancer (OPEN/TORG2040)

Rationale and protocol design of a phase II study of first-line osimertinib treatment for patients with poor performance status and EGFR mutation-positive non-small cell lung cancer (OPEN/TORG2040)
6    8    1
EOAI, a ubiquitin-specific peptidase 5 inhibitor, prevents non-small cell lung cancer progression by inducing DNA damage

EOAI, a ubiquitin-specific peptidase 5 inhibitor, prevents non-small cell lung cancer progression by inducing DNA damage
18    8    1
Phase II study of carboplatin/nab-paclitaxel/ atezolizumab combination therapy for advanced nonsquamous non–small cell lung cancer patients with impaired renal function: RESTART trial

Phase II study of carboplatin/nab-paclitaxel/ atezolizumab combination therapy for advanced nonsquamous non–small cell lung cancer patients with impaired renal function: RESTART trial
5    1    1
Development and validation of a prognostic nomogram for early stage non-small cell lung cancer: A study based on the SEER database and a Chinese cohort

Development and validation of a prognostic nomogram for early stage non-small cell lung cancer: A study based on the SEER database and a Chinese cohort
13    1    1
Real-world analysis of different intracranial radiation therapies in non-small cell lung cancer patients with 1–4 brain metastases

Real-world analysis of different intracranial radiation therapies in non-small cell lung cancer patients with 1–4 brain metastases
14    1    1
Association between the efcacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: A retrospective study

Association between the efcacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: A retrospective study
10    1    1
Impact of BMI on the survival outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis

Impact of BMI on the survival outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis
14    1    1
First-line treatment with TKI plus brain radiotherapy versus TKI alone in EGFRmutated non-small cell Lung cancer with brain metastases: A systematic review and meta-analysis

First-line treatment with TKI plus brain radiotherapy versus TKI alone in EGFRmutated non-small cell Lung cancer with brain metastases: A systematic review and meta-analysis
11    3    1
Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: A multicenter study

Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: A multicenter study
9    4    1
Dual targeting of MEK and PI3K efectively controls the proliferation of human EGFR-TKI resistant non-small cell lung carcinoma cell lines with diferent genetic backgrounds

Dual targeting of MEK and PI3K efectively controls the proliferation of human EGFR-TKI resistant non-small cell lung carcinoma cell lines with diferent genetic backgrounds
12    38    1
LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR433-3p to upregulate WTAP

LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR433-3p to upregulate WTAP
11    37    1
A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer

A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer
8    85    0